Day Range2.200 - 2.290 | 52 Wk Range0.290 - 3.590 | Open / Close2.250 / 2.200 | Float / Outstanding260.700M / 260.700M |
Vol / Avg.2.180M / 3.831M | Mkt Cap573.540M | P/E- | 50d Avg. Price2.330 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float260.700M | EPS-1.170 |
SNDL Stock (NASDAQ: SNDL) stock price, news, charts, stock research, profile.
Day Range2.200 - 2.290 | 52 Wk Range0.290 - 3.590 | Open / Close2.250 / 2.200 | Float / Outstanding260.700M / 260.700M |
Vol / Avg.2.180M / 3.831M | Mkt Cap573.540M | P/E- | 50d Avg. Price2.330 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float260.700M | EPS-1.170 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-28 | ||||||
REV |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.030 | -0.050 | -0.0200 | ||||
REV | 168.660M | 230.500M | 61.840M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of SNDL (NASDAQ: SNDL) through any online brokerage.
Other companies in SNDL’s space includes: Theravance Biopharma (NASDAQ:TBPH), GH Research (NASDAQ:GHRS), WAVE Life Sciences (NASDAQ:WVE), CymaBay Therapeutics (NASDAQ:CBAY) and Phibro Animal Health (NASDAQ:PAHC).
The latest price target for SNDL (NASDAQ: SNDL) was reported by Cantor Fitzgerald on Monday, November 28, 2022. The analyst firm set a price target for 3.60 expecting SNDL to rise to within 12 months (a possible 63.64% upside). 5 analyst firms have reported ratings in the last year.
The stock price for SNDL (NASDAQ: SNDL) is $2.2 last updated February 8, 2023 at 9:00 PM UTC.
There are no upcoming dividends for SNDL.
SNDL’s Q4 earnings are confirmed for Tuesday, March 28, 2023.
There is no upcoming split for SNDL.
SNDL is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
SNDL Stock (NASDAQ: SNDL) stock price, news, charts, stock research, profile.
Day Range2.200 - 2.290 | 52 Wk Range0.290 - 3.590 | Open / Close2.250 / 2.200 | Float / Outstanding260.700M / 260.700M |
Vol / Avg.2.180M / 3.831M | Mkt Cap573.540M | P/E- | 50d Avg. Price2.330 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float260.700M | EPS-1.170 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-28 | ||||||
REV |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.030 | -0.050 | -0.0200 | ||||
REV | 168.660M | 230.500M | 61.840M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of SNDL (NASDAQ: SNDL) through any online brokerage.
Other companies in SNDL’s space includes: Theravance Biopharma (NASDAQ:TBPH), GH Research (NASDAQ:GHRS), WAVE Life Sciences (NASDAQ:WVE), CymaBay Therapeutics (NASDAQ:CBAY) and Phibro Animal Health (NASDAQ:PAHC).
The latest price target for SNDL (NASDAQ: SNDL) was reported by Cantor Fitzgerald on Monday, November 28, 2022. The analyst firm set a price target for 3.60 expecting SNDL to rise to within 12 months (a possible 63.64% upside). 5 analyst firms have reported ratings in the last year.
The stock price for SNDL (NASDAQ: SNDL) is $2.2 last updated February 8, 2023 at 9:00 PM UTC.
There are no upcoming dividends for SNDL.
SNDL’s Q4 earnings are confirmed for Tuesday, March 28, 2023.
There is no upcoming split for SNDL.
SNDL is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
SNDL Stock (NASDAQ: SNDL) stock price, news, charts, stock research, profile.
Day Range2.200 - 2.290 | 52 Wk Range0.290 - 3.590 | Open / Close2.250 / 2.200 | Float / Outstanding260.700M / 260.700M |
Vol / Avg.2.180M / 3.831M | Mkt Cap573.540M | P/E- | 50d Avg. Price2.330 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float260.700M | EPS-1.170 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-28 | ||||||
REV |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.030 | -0.050 | -0.0200 | ||||
REV | 168.660M | 230.500M | 61.840M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of SNDL (NASDAQ: SNDL) through any online brokerage.
Other companies in SNDL’s space includes: Theravance Biopharma (NASDAQ:TBPH), GH Research (NASDAQ:GHRS), WAVE Life Sciences (NASDAQ:WVE), CymaBay Therapeutics (NASDAQ:CBAY) and Phibro Animal Health (NASDAQ:PAHC).
The latest price target for SNDL (NASDAQ: SNDL) was reported by Cantor Fitzgerald on Monday, November 28, 2022. The analyst firm set a price target for 3.60 expecting SNDL to rise to within 12 months (a possible 63.64% upside). 5 analyst firms have reported ratings in the last year.
The stock price for SNDL (NASDAQ: SNDL) is $2.2 last updated February 8, 2023 at 9:00 PM UTC.
There are no upcoming dividends for SNDL.
SNDL’s Q4 earnings are confirmed for Tuesday, March 28, 2023.
There is no upcoming split for SNDL.
SNDL is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
SNDL Stock (NASDAQ: SNDL) stock price, news, charts, stock research, profile.
Day Range2.200 - 2.290 | 52 Wk Range0.290 - 3.590 | Open / Close2.250 / 2.200 | Float / Outstanding260.700M / 260.700M |
Vol / Avg.2.180M / 3.831M | Mkt Cap573.540M | P/E- | 50d Avg. Price2.330 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float260.700M | EPS-1.170 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-28 | ||||||
REV |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.030 | -0.050 | -0.0200 | ||||
REV | 168.660M | 230.500M | 61.840M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of SNDL (NASDAQ: SNDL) through any online brokerage.
Other companies in SNDL’s space includes: Theravance Biopharma (NASDAQ:TBPH), GH Research (NASDAQ:GHRS), WAVE Life Sciences (NASDAQ:WVE), CymaBay Therapeutics (NASDAQ:CBAY) and Phibro Animal Health (NASDAQ:PAHC).
The latest price target for SNDL (NASDAQ: SNDL) was reported by Cantor Fitzgerald on Monday, November 28, 2022. The analyst firm set a price target for 3.60 expecting SNDL to rise to within 12 months (a possible 63.64% upside). 5 analyst firms have reported ratings in the last year.
The stock price for SNDL (NASDAQ: SNDL) is $2.2 last updated February 8, 2023 at 9:00 PM UTC.
There are no upcoming dividends for SNDL.
SNDL’s Q4 earnings are confirmed for Tuesday, March 28, 2023.
There is no upcoming split for SNDL.
SNDL is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
SNDL Stock (NASDAQ: SNDL) stock price, news, charts, stock research, profile.
Day Range2.200 - 2.290 | 52 Wk Range0.290 - 3.590 | Open / Close2.250 / 2.200 | Float / Outstanding260.700M / 260.700M |
Vol / Avg.2.180M / 3.831M | Mkt Cap573.540M | P/E- | 50d Avg. Price2.330 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float260.700M | EPS-1.170 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-28 | ||||||
REV |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.030 | -0.050 | -0.0200 | ||||
REV | 168.660M | 230.500M | 61.840M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of SNDL (NASDAQ: SNDL) through any online brokerage.
Other companies in SNDL’s space includes: Theravance Biopharma (NASDAQ:TBPH), GH Research (NASDAQ:GHRS), WAVE Life Sciences (NASDAQ:WVE), CymaBay Therapeutics (NASDAQ:CBAY) and Phibro Animal Health (NASDAQ:PAHC).
The latest price target for SNDL (NASDAQ: SNDL) was reported by Cantor Fitzgerald on Monday, November 28, 2022. The analyst firm set a price target for 3.60 expecting SNDL to rise to within 12 months (a possible 63.64% upside). 5 analyst firms have reported ratings in the last year.
The stock price for SNDL (NASDAQ: SNDL) is $2.2 last updated February 8, 2023 at 9:00 PM UTC.
There are no upcoming dividends for SNDL.
SNDL’s Q4 earnings are confirmed for Tuesday, March 28, 2023.
There is no upcoming split for SNDL.
SNDL is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
SNDL Stock (NASDAQ: SNDL) stock price, news, charts, stock research, profile.
Day Range2.200 - 2.290 | 52 Wk Range0.290 - 3.590 | Open / Close2.250 / 2.200 | Float / Outstanding260.700M / 260.700M |
Vol / Avg.2.180M / 3.831M | Mkt Cap573.540M | P/E- | 50d Avg. Price2.330 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float260.700M | EPS-1.170 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-28 | ||||||
REV |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.030 | -0.050 | -0.0200 | ||||
REV | 168.660M | 230.500M | 61.840M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of SNDL (NASDAQ: SNDL) through any online brokerage.
Other companies in SNDL’s space includes: Theravance Biopharma (NASDAQ:TBPH), GH Research (NASDAQ:GHRS), WAVE Life Sciences (NASDAQ:WVE), CymaBay Therapeutics (NASDAQ:CBAY) and Phibro Animal Health (NASDAQ:PAHC).
The latest price target for SNDL (NASDAQ: SNDL) was reported by Cantor Fitzgerald on Monday, November 28, 2022. The analyst firm set a price target for 3.60 expecting SNDL to rise to within 12 months (a possible 63.64% upside). 5 analyst firms have reported ratings in the last year.
The stock price for SNDL (NASDAQ: SNDL) is $2.2 last updated February 8, 2023 at 9:00 PM UTC.
There are no upcoming dividends for SNDL.
SNDL’s Q4 earnings are confirmed for Tuesday, March 28, 2023.
There is no upcoming split for SNDL.
SNDL is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
SNDL Stock (NASDAQ: SNDL) stock price, news, charts, stock research, profile.
Day Range2.200 - 2.290 | 52 Wk Range0.290 - 3.590 | Open / Close2.250 / 2.200 | Float / Outstanding260.700M / 260.700M |
Vol / Avg.2.180M / 3.831M | Mkt Cap573.540M | P/E- | 50d Avg. Price2.330 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float260.700M | EPS-1.170 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-28 | ||||||
REV |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.030 | -0.050 | -0.0200 | ||||
REV | 168.660M | 230.500M | 61.840M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of SNDL (NASDAQ: SNDL) through any online brokerage.
Other companies in SNDL’s space includes: Theravance Biopharma (NASDAQ:TBPH), GH Research (NASDAQ:GHRS), WAVE Life Sciences (NASDAQ:WVE), CymaBay Therapeutics (NASDAQ:CBAY) and Phibro Animal Health (NASDAQ:PAHC).
The latest price target for SNDL (NASDAQ: SNDL) was reported by Cantor Fitzgerald on Monday, November 28, 2022. The analyst firm set a price target for 3.60 expecting SNDL to rise to within 12 months (a possible 63.64% upside). 5 analyst firms have reported ratings in the last year.
The stock price for SNDL (NASDAQ: SNDL) is $2.2 last updated February 8, 2023 at 9:00 PM UTC.
There are no upcoming dividends for SNDL.
SNDL’s Q4 earnings are confirmed for Tuesday, March 28, 2023.
There is no upcoming split for SNDL.
SNDL is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
SNDL Stock (NASDAQ: SNDL) stock price, news, charts, stock research, profile.
Day Range2.200 - 2.290 | 52 Wk Range0.290 - 3.590 | Open / Close2.250 / 2.200 | Float / Outstanding260.700M / 260.700M |
Vol / Avg.2.180M / 3.831M | Mkt Cap573.540M | P/E- | 50d Avg. Price2.330 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float260.700M | EPS-1.170 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-28 | ||||||
REV |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.030 | -0.050 | -0.0200 | ||||
REV | 168.660M | 230.500M | 61.840M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of SNDL (NASDAQ: SNDL) through any online brokerage.
Other companies in SNDL’s space includes: Theravance Biopharma (NASDAQ:TBPH), GH Research (NASDAQ:GHRS), WAVE Life Sciences (NASDAQ:WVE), CymaBay Therapeutics (NASDAQ:CBAY) and Phibro Animal Health (NASDAQ:PAHC).
The latest price target for SNDL (NASDAQ: SNDL) was reported by Cantor Fitzgerald on Monday, November 28, 2022. The analyst firm set a price target for 3.60 expecting SNDL to rise to within 12 months (a possible 63.64% upside). 5 analyst firms have reported ratings in the last year.
The stock price for SNDL (NASDAQ: SNDL) is $2.2 last updated February 8, 2023 at 9:00 PM UTC.
There are no upcoming dividends for SNDL.
SNDL’s Q4 earnings are confirmed for Tuesday, March 28, 2023.
There is no upcoming split for SNDL.
SNDL is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
SNDL Stock (NASDAQ: SNDL) stock price, news, charts, stock research, profile.
Day Range2.200 - 2.290 | 52 Wk Range0.290 - 3.590 | Open / Close2.250 / 2.200 | Float / Outstanding260.700M / 260.700M |
Vol / Avg.2.180M / 3.831M | Mkt Cap573.540M | P/E- | 50d Avg. Price2.330 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float260.700M | EPS-1.170 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-28 | ||||||
REV |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.030 | -0.050 | -0.0200 | ||||
REV | 168.660M | 230.500M | 61.840M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of SNDL (NASDAQ: SNDL) through any online brokerage.
Other companies in SNDL’s space includes: Theravance Biopharma (NASDAQ:TBPH), GH Research (NASDAQ:GHRS), WAVE Life Sciences (NASDAQ:WVE), CymaBay Therapeutics (NASDAQ:CBAY) and Phibro Animal Health (NASDAQ:PAHC).
The latest price target for SNDL (NASDAQ: SNDL) was reported by Cantor Fitzgerald on Monday, November 28, 2022. The analyst firm set a price target for 3.60 expecting SNDL to rise to within 12 months (a possible 63.64% upside). 5 analyst firms have reported ratings in the last year.
The stock price for SNDL (NASDAQ: SNDL) is $2.2 last updated February 8, 2023 at 9:00 PM UTC.
There are no upcoming dividends for SNDL.
SNDL’s Q4 earnings are confirmed for Tuesday, March 28, 2023.
There is no upcoming split for SNDL.
SNDL is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.